What You Need to Know About HER2

Overview

HER2 is a critical concept in the world of breast cancer that plays a significant role in diagnosis, treatment, and overall prognosis. This article aims to provide comprehensive information about HER2, its importance in breast cancer, and how it affects the lives of those with the condition. Throughout the following sections, you will gain an understanding of what HER2 means, the process of testing for HER2 status, available treatment options, and what it's like to live with HER2-positive breast cancer. Additionally, we'll discuss support resources and address some frequently asked questions to empower you and your loved ones with the essential knowledge for navigating this journey.

HER2 Defined

HER2, which stands for Human Epidermal Growth Factor Receptor 2, is a protein that occurs naturally on the surface of some breast cells. It plays a key role in promoting cell growth, division, and repair by receiving growth signals from outside the cell and transmitting them to the cell's interior.

In some cases, breast cells can have an overabundance of HER2 receptors, leading to rapid and uncontrolled cell growth. This condition is known as HER2-positive breast cancer. About 20-25% of breast cancer cases are classified as HER2-positive, making it an essential factor to consider during diagnosis and treatment planning.

There are four primary subtypes of breast cancer, and they are categorized based on the presence or absence of specific receptors, such as HER2:

• HER2-positive: Cancer cells have excess HER2 receptors, leading to aggressive cell growth.
• Estrogen receptor-positive (ER): Cancer cells have estrogen receptors, meaning they grow in response to estrogen.
• Progesterone receptor-positive (PR): Cancer cells have progesterone receptors, meaning they grow in response to progesterone.
• Triple-negative: Cancer cells do not have HER2, estrogen, or progesterone receptors, making this subtype challenging to treat.

Determining the subtype of breast cancer is crucial as it affects the treatment approach and the overall prognosis for the patient. HER2-positive breast cancer tends to be more aggressive and may require different therapeutic methods compared to other subtypes. However, over the past few decades, significant advancements in targeted therapies have improved the outcomes for HER2-positive breast cancer patients.

Testing for HER2 Status

Identifying the HER2 status of a breast cancer patient is a critical part of the diagnostic process. It helps oncologists choose the most appropriate treatment plan tailored to the patient's specific cancer subtype. There are a few techniques used to determine HER2 status, including:

• Immunohistochemistry (IHC): This test measures the amount of HER2 protein present on the surface of cancer cells using special staining techniques. The results are scored on a scale of 0 to 3+ based on the intensity of the staining. A score of 0 to 1+ indicates HER2-negative, while 3+ reflects HER2-positive status. If the IHC test result is 2+ (equivocal), further testing is needed through other methods to confirm the HER2 status.
• Fluorescence in situ hybridization (FISH): FISH uses fluorescently labeled DNA probes to detect the specific her2 gene within the cancer cells. The results indicate whether the her2 gene has an abnormal number of copies (amplified) or a normal number (non-amplified). Patients with an amplified her2 gene are considered HER2-positive.
• Silver in situ hybridization (SISH) and chromogenic in situ hybridization (CISH): Similar to FISH, these tests assess the number of her2 gene copies within the cancer cells using silver or chromogenic labeling instead of fluorescence. They help provide a clearer picture of the patient's HER2 status when IHC results are unclear.

Typically, IHC is the initial test performed during the diagnostic process, followed by FISH, SISH, or CISH if further clarification is needed.

It's important to perform these tests accurately since they play a crucial role in the tailored treatment planning for each patient. Depending on the diagnosis and the HER2 test results, the oncologist may recommend specific targeted therapies designed to inhibit HER2-positive breast cancer growth.

Remember that HER2 status can change over time, especially in cases of cancer recurrence or metastasis. In such scenarios, oncologists may recommend repeating HER2 testing procedures to ensure an up-to-date understanding of the patient's breast cancer subtype and customized treatment strategy.

Treatment Options

HER2-positive breast cancer patients have access to various treatment options targeting the HER2 protein specifically. These treatments help slow down the cancer's progression and improve the patient's prognosis. It's vital to discuss the best approach with your healthcare team, as your treatment plan may combine multiple therapies depending on the cancer stage and other individual factors. Targeted therapies for HER2-positive breast cancer include:

• Trastuzumab (Herceptin): This is a HER2-targeted monoclonal antibody, blocking the growth signals of cancer cells and inducing an immune response against them. Trastuzumab is often used in combination with chemotherapy for early-stage HER2-positive breast cancer patients or as a single agent for metastatic HER2-positive breast cancer.
• Pertuzumab (Perjeta): Pertuzumab is another HER2-targeted monoclonal antibody, working in synergy with trastuzumab to enhance its anticancer effects. It is often combined with trastuzumab and chemotherapy as a neoadjuvant (before surgery) or adjuvant (after surgery) therapy for early-stage HER2-positive breast cancer patients.
• T-DM1 (Ado-trastuzumab emtansine; Kadcyla): This is a HER2-targeted antibody-drug conjugate that links trastuzumab to a potent chemotherapy drug. T-DM1 is utilized for patients with metastatic HER2-positive breast cancer that has progressed despite treatment with trastuzumab and a taxane chemotherapy drug.
• Neratinib (Nerlynx): Neratinib is a small molecule tyrosine kinase inhibitor that blocks multiple proteins, including HER2. It’s used as extended adjuvant therapy for early-stage HER2-positive breast cancer patients who have completed a year of trastuzumab-based therapy.
• Lapatinib (Tykerb): Lapatinib is another small molecule tyrosine kinase inhibitor that targets both HER2 and the epidermal growth factor receptor (EGFR). It is used in combination with chemotherapy or hormone therapy for treating metastatic HER2-positive breast cancer patients who have progressed on previous treatments.

It's essential to consider each patient's unique situation when devising a treatment plan, taking into account factors such as overall health, age, cancer stage, and response to previous treatments. Your healthcare team will guide you in making the best decisions to manage your HER2-positive breast cancer effectively. Note that targeted treatments can cause side effects, so closely monitoring your condition and reporting concerns to your healthcare team will help manage any adverse reactions and optimize your treatment experience.

Living with HER2-Positive Breast Cancer

Receiving a HER2-positive breast cancer diagnosis can be overwhelming, but it's important to remember that you can still lead a fulfilling life with the condition. Here are some practical tips and strategies to help you navigate through the journey:

• Stay informed: Educate yourself about HER2-positive breast cancer and its implications. Understanding your health condition will enable you to discuss your options with your healthcare team, make informed decisions, and advocate for your needs.
• Keep a supportive network: Connect with family, friends, or support groups to share your feelings, thoughts, and experiences. Building a strong support system can assist with coping, alleviating stress, and improving your overall quality of life.
• Maintain a healthy lifestyle: A balanced diet, regular exercise, and stress management techniques can help you feel better, improve your immune system, and enhance your overall well-being. Consult your healthcare team for tailored advice on healthy living with HER2-positive breast cancer.
• Stay up-to-date with appointments: Attend all your scheduled medical appointments and actively engage in your care. This will help ensure your treatment is on track and allow your healthcare team to monitor your progress and address any concerns promptly.
• Manage side effects: Speak openly with your healthcare team about any side effects you experience from treatments. They will guide you on managing these issues, which may include using medications, modifying your daily activities, or integrating complementary therapies like massage or acupuncture.
• Seek financial assistance: Cancer treatments and related expenses can be challenging to navigate. Discuss available resources with your healthcare team, certified patient navigators, or social workers to help cover costs and manage your financial well-being.
• Plan for the future: While living with HER2-positive breast cancer, it's essential to strike a balance between seeking treatment, managing side effects, and maintaining quality of life. Planning for career, family, and personal goals can help provide a sense of purpose and direction amidst the challenges of the condition.

Living with HER2-positive breast cancer is a journey that may require adjustments and resilience. Remember, you're not alone; your healthcare team, support network, and fellow patients can provide valuable emotional, physical, and psychological support throughout your experience.

Support and Resources

It's crucial to have access to resources and support networks when facing a HER2-positive breast cancer diagnosis. These organizations and tools can help you cope with your condition, provide additional information, and connect you with other individuals in similar circumstances:

• Breast Cancer Organizations: Many national and local organizations offer specialized support to those affected by breast cancer. Examples include the American Cancer Society, Susan G. Komen Foundation, Young Survival Coalition, and Living Beyond Breast Cancer. These organizations provide educational materials, advocacy initiatives, and support services to assist you throughout your journey.
• Online Communities and Support Groups: Digital platforms, such as breastcancer.org forums, Inspire, and CancerCare, offer online communities where you can connect with others who have HER2-positive breast cancer for emotional support, practical tips, and shared experiences. Some organizations also provide local support groups and in-person meetings to foster connections.
• Financial Assistance Programs: Many organizations and foundations offer financial assistance or grant programs for breast cancer patients in need. Your healthcare team, social worker, or patient navigator can help direct you to appropriate resources for your specific situation.
• Complementary and Alternative Therapies: Complementary therapies, such as relaxation techniques, yoga, meditation, and acupuncture, can aid in reducing stress, managing symptoms, and enhancing overall well-being. Speak with your healthcare team about incorporating these therapies into your care plan.
• Counseling and Therapy Services: Professional counseling services, including individual or group therapy, can provide valuable emotional support and coping strategies. Your healthcare team can connect you with recommended therapists who are familiar with the unique challenges associated with HER2-positive breast cancer.
• Healthcare Communication Tools: Keep track of your medical information, appointments, and communication with your healthcare team using organizational tools and apps. There are several cancer-specific apps available, such as Cancer.Net Mobile, My Cancer Coach, and Belong: Beating Cancer Together, which can help you manage your medical journey.

Having a robust support network and resources at your disposal is essential in managing life with HER2-positive breast cancer. Don't hesitate to explore these valuable resources and reach out for the assistance you need as you navigate your treatment and recovery.

Frequently Asked Questions

Below are some commonly asked questions related to HER2 and HER2-positive breast cancer:

• What does HER2-positive mean? HER2-positive means that the cancer cells have excessive amounts of the HER2 protein on their surface. This protein can help cancer cells grow and divide more quickly, leading to more aggressive cancer. About 20-25% of breast cancer patients have HER2-positive tumors.
• Is HER2-positive breast cancer more aggressive? Yes, HER2-positive breast cancers tend to be more aggressive than those that are HER2-negative. They may grow more quickly, are more likely to spread, and have a higher risk of recurrence. However, targeted therapies have greatly improved outcomes for patients with this type of cancer.
• How is HER2-positive breast cancer different from other types? HER2-positive breast cancer is different because it is specifically driven by the overexpression of the HER2 protein. This characteristic guides treatment options, as HER2-targeted therapies have been developed to block the HER2 protein and its function in cancer progression.
• Can HER2 status change over time? Yes, it is possible for the HER2 status to change during the course of breast cancer, either from HER2-positive to HER2-negative, or vice versa. It is important to re-test the HER2 status if the cancer recurs or metastasizes (spreads) to ensure the appropriate treatment is given.
• How often is HER2 testing conducted? HER2 testing is typically done at the initial breast cancer diagnosis, as it directly impacts the treatment plan. Testing may be repeated if the cancer recurs or spreads to other parts of the body to determine the most effective treatment options.
• What are the side effects of HER2-targeted therapies? Side effects of HER2-targeted therapies vary depending on the specific drug used. Common side effects can include diarrhea, fatigue, rash, and heart problems. It is critical to inform your healthcare team if you experience any side effects, as they can provide recommendations on managing them.
• What is the prognosis for someone with HER2-positive breast cancer? While HER2-positive breast cancer is considered more aggressive, the availability of targeted therapies has greatly improved prognosis. Treatment outcomes vary based on the stage of cancer, the individual's overall health, and response to therapy, but many patients with HER2-positive breast cancer have a positive outlook.

If you have additional questions or concerns regarding HER2-positive breast cancer, it is crucial to speak with your healthcare team. They can provide specific information tailored to your situation and help guide you through your treatment journey.

Learn more about SurvivorNet's rigorous medical review process.